The result is a medication that progressively loses its ability to bind receptors and produce the effects you need for weight management and metabolic health
According to that same label, the types and frequency of common adverse reactions for the oral tablet are similar to those of the injection
The first symptom of NAION is usually that one eye suddenly and painlessly goes blind as the optic nerve stops receiving enough blood
Reference: Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trial by Rohit Loomba, Erin Morgan, Keyvan Yousefi, Dan Li, Richard Geary, Sanjay Bhanot and Naim Alkhouri, 23 August 2025, The Lancet
Commonly referred to as age-related macular degeneration (AMD)